Literature DB >> 6196464

HLA antigens-linked genetic control in multiple sclerosis patients resistant and susceptible to infection.

G Lamoureux, P Duquette, Y Lapierre, B Cosgrove, G Bourret, L Labrie.   

Abstract

Patients with multiple sclerosis (MS) from the two Montreal MS clinics, were divided into two groups: one group of 61 patients (MS type I) who had no clinical history of susceptibility to recurrent respiratory tract infections and a second group of 58 patients (MS type II) who had persistent susceptibility to such infections since childhood. All patients were typed for the HLA tissue antigens. The HLA antigen frequencies of the total MS patient population, and of MS type I and MS type II patients were compared to those of a normal control population and each other. The HLA-DR2 and B7 antigen frequencies were significantly increased compared to the normal controls for all MS patients. MS type I patients had an increased frequency for HLA-Bw42 and DRw8 antigens; the frequency of HLA-A29 was lower than in the controls and MS type II patients. MS type II patients had a significantly increased frequency for DR3 and some HLA-DR3-associated phenotypes (A1 + DR3; B8 + DR3; A1 + B8 + DR3) as compared to controls and MS type I patients. These results are consistent with the existence of genes linked to the HLA antigens, such as immune response genes, which control the resistance or susceptibility of the patients to infection, and suggest that these HLA antigens could be associated with a difference in the evolution of MS, as observed in the MS type I and II patients [21].

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6196464     DOI: 10.1007/bf00313636

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  24 in total

1.  PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

Authors:  G A SCHUMACHER; G BEEBE; R F KIBLER; L T KURLAND; J F KURTZKE; F MCDOWELL; B NAGLER; W A SIBLEY; W W TOURTELLOTTE; T L WILLMON
Journal:  Ann N Y Acad Sci       Date:  1965-03-31       Impact factor: 5.691

2.  Immunogenetical aspects of multiple sclerosis with special regard to the HLA-histocompatibility system.

Authors:  J Bertrams
Journal:  Boll Ist Sieroter Milan       Date:  1978-01-31

Review 3.  The association between genes in the major histocompatibility complex and disease susceptibility,.

Authors:  T Sasazuki; H O McDevitt; F C Grumet
Journal:  Annu Rev Med       Date:  1977       Impact factor: 13.739

4.  [HLA antigens and susceptibility to disease].

Authors:  J Bertrams
Journal:  Dtsch Med Wochenschr       Date:  1976-01-30       Impact factor: 0.628

5.  Association of autoimmune active chronic hepatitis with HL-A1,8.

Authors:  I R Mackay; P J Morris
Journal:  Lancet       Date:  1972-10-14       Impact factor: 79.321

6.  Prior events in multiple sclerosis.

Authors:  R D Currier; E A Martin; P C Woosley
Journal:  Neurology       Date:  1974-08       Impact factor: 9.910

7.  Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.

Authors:  K K Mittal; M R Mickey; D P Singal; P I Terasaki
Journal:  Transplantation       Date:  1968-11       Impact factor: 4.939

8.  Separation of leukocytes from blood and bone marrow. Introduction.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

9.  Past infectious events and disease evolution in multiple sclerosis.

Authors:  G Lamoureux; Y Lapierre; G Ducharme
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

10.  [Multiple sclerosis: a multi-specific immune deficiency disease].

Authors:  G Lamoureux; J Toupin; F Leyva
Journal:  Ann Immunol (Paris)       Date:  1977 Jan-Mar
View more
  3 in total

1.  HLA antigens in Italian multiple sclerosis patients.

Authors:  L La Mantia; M T Illeni; C Milanese; A Salmaggi; M Eoli; G Pellegris; A Nespolo
Journal:  Ital J Neurol Sci       Date:  1991-02

2.  Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans.

Authors:  Zeying Du; David W Gjertson; Elaine F Reed; Raja Rajalingam
Journal:  Immunogenetics       Date:  2006-11-14       Impact factor: 2.846

3.  Identification of a locus on mouse chromosome 3 involved in differential susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease.

Authors:  R W Melvold; D M Jokinen; S D Miller; M C Dal Canto; H L Lipton
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.